AVOQ, LLC

Lobbying for BIOTECHNOLOGY INNOVATION ORGANIZATION · â€‹Trade association.

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $80,000.00 income · posted Apr 20, 2026

Lobbying activity 2

Health Issues

General issues related to health care, including Most Favored Nation drug pricing

Trade (domestic/foreign)

Issues related to international trade including tariffs

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.